The Brutalist Report

MarketWatch

• : Ardelyx wins long battle for FDA approval of kidney-disease treatment [996d]
• Dow Jones Newswires: Impact Biomedical files for IPO [996d]
• The Ratings Game: ‘Unprecedented’ AI server buildout may be happening too quickly, this analyst warns [997d]
• Therese Poletti's Tech Tales: AI stole the show this year, but earnings will drag Wall Street back to reality [997d]